|
시장보고서
상품코드
2148317
차세대 세포 치료 시장 : 세포 유형별, 요법 유형별, 유래별, 용도별, 최종사용자별, 지역별Next Generation Cell Therapy Market, By Cell Type, By Therapy Type, By Source, By Application, By End User, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
차세대 세포 치료 시장 규모는 2026년에 74억 달러로 추정되며, 2033년까지 358억 8,000만 달러에 달할 것으로 전망됩니다. 2026년부터 2033년까지 CAGR 25.3%로 성장할 것으로 예측됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 74억 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간의 CAGR: | 25.30% | 2033년 시장 규모 예측: | 358억 8,000만 달러 |
세계 차세대 세포 치료 시장은 살아있는 세포를 이용하여 손상된 조직을 복구, 대체 또는 재생시켜 복잡한 질환을 치료하는 첨단 치료법을 포괄합니다. 이러한 치료법에는 CAR-T, NK 세포, iPS 세포 유래 및 유전자 편집을 거친 세포 치료가 포함되며, 종양학, 자가면역 질환, 심혈관질환, 희귀 유전성 질환 등 광범위한 분야에서 응용되고 있습니다.
합성생물학, CRISPR 기반 유전체 공학, 그리고 세포 제조 기술의 발전으로 인해 이러한 치료법은 연구 단계에서 임상 및 상업적 응용 단계로 전환되고 있습니다. 한편, 규제 측면에서의 지원 강화, 제조의 확장성 향상, 그리고 첨단 세포 기술에 대한 투자 확대가 전 세계적으로 차세대 세포 치료법의 개발과 보급을 더욱 가속화하고 있습니다.
시장 역학
세계 차세대 세포 치료 시장은 암 및 만성 질환의 발병률 증가, 유전자 변형 세포 치료의 임상적 유효성 입증이 진행되고 있는 점, 그리고 CRISPR-Cas9 및 염기 편집과 같은 유전자 편집 기술의 발전에 의해 주도되고 있습니다. 규제 측면에서의 지원 강화, 정부의 자금 지원, 그리고 동종 ‘오프 더 셸프(off-the-shelf)’ 요법의 개발 또한 상용화를 가속화하고 환자의 접근성을 확대하는 요인입니다.
그러나 시장에는 높은 제조 비용, 복잡한 맞춤형 생산, 콜드체인 요건, 엄격한 품질 관리 등 많은 제약이 존재합니다. 그럼에도 불구하고, 생명공학, 제약, 연구 기관 간의 협력 강화에 힘입어 동종 세포 치료, AI를 활용한 제조 및 환자 선정, 그리고 고형암, 자가면역 질환, 신경 질환으로의 적용 확대 분야에서 큰 기회가 존재하고 있습니다.
본 조사의 주요 특징
- 본 조사에서는 다양한 부문의 잠재적 수익 기회를 밝히고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 해설하고 있습니다.
- 또한, 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하고 있는 경쟁 전략에 관한 중요한 인사이트도 제공합니다.
- 본 조사에서는 다음 매개변수(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 바탕으로 전 세계 차세대 세포 치료제 시장의 주요 기업 개요를 소개하고 있습니다.
- 본 보고서에서 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 유형 업그레이드, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있습니다.
- 본 ‘전 세계 차세대 세포 치료 시장’ 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 전 세계 차세대 세포 치료 시장 분석에 사용된 다양한 전략 매트릭스를 활용하여 원활하게 의사결정을 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 차세대 세포 치료 시장 : 세포 유형별, 2021-2033년
제5장 세계의 차세대 세포 치료 시장 : 요법 유형별, 2021-2033년
제6장 세계의 차세대 세포 치료 시장 : 유래별, 2021-2033년
제7장 세계의 차세대 세포 치료 시장 : 용도별, 2021-2033년
제8장 세계의 차세대 세포 치료 시장 : 최종사용자별, 2021-2033년
제9장 세계의 차세대 세포 치료 시장 : 지역별, 2021-2033년
제10장 경쟁 구도
제11장 애널리스트의 제안
제12장 참고문헌 및 조사 방법
KSM 26.10.22Next Generation Cell Therapy Market is estimated to be valued at USD 7.40 Bn in 2026 and is expected to reach USD 35.88 Bn by 2033, growing at a compound annual growth rate (CAGR) of 25.3% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 7.40 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 25.30% | 2033 Value Projection: | USD 35.88 Bn |
The global next generation cell therapy market encompasses advanced therapies that utilize living cells to repair, replace or regenerate damaged tissues and treat complicated diseases. These therapies include CAR-T, NK cell, iPSC-derived and gene edited cell therapies with applications across oncology, auto-immune disorders, cardiovascular diseases and rare genetic conditions.
Advances in synthetic biology, CRISPR-based genome engineering and cell manufacturing are driving these therapies from research to clinical and commercial applications, while increasing regulatory support, improving manufacturing scalability and increased investment in advanced cellular technologies are further accelerating the development and adoption of next generation cell therapies globally.
Market Dynamics
The global next generation cell therapy market is driven by the increasing incidence of cancer and chronic diseases, increasing clinical validation of engineered cell therapies and advancements in gene-editing technologies such as CRISPR-Cas9 and base editing. Increasing regulatory support, government funding and development of allogeneic "off-the-shelf" therapies are other factors that are accelerating commercialization and expanding patient accessibility.
However, a number of constraints are present in the market, such as high manufacturing costs, complex personalized production, cold-chain requirements and stringent quality controls. Nevertheless, significant opportunities exist within allogeneic cell therapies, AI-enabled manufacturing and patient selection and expansion into solid tumors, autoimmune diseases and neurological disorders supported by increasing collaboration across biotechnology, pharmaceutical and research organizations.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global next generation cell therapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Novartis AG, Bristol-Myers Squibb Company, Gilead Sciences, Inc., Johnson & Johnson, Legend Biotech Corporation, Autolus Therapeutics plc, Iovance Biotherapeutics, Inc., Adaptimmune Therapeutics plc, Allogene Therapeutics, Inc., and CRISPR Therapeutics AG
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global next generation cell therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global next generation cell therapy market
Market Segmentation
- Cell Type Insights (Revenue, USD Bn, 2021 - 2033)
- T Cells
- Natural Killer (NK) Cells
- Stem Cells
- Dendritic Cells
- Macrophages
- Others
- Therapy Type Insights (Revenue, USD Bn, 2021 - 2033)
- CAR-T Cell Therapy
- T-Cell Receptor (TCR) Therapy
- Tumor-Infiltrating Lymphocyte (TIL) Therapy
- CAR-NK Cell Therapy
- Stem Cell Therapy
- Others
- Source Insights (Revenue, USD Bn, 2021 - 2033)
- Autologous
- Allogeneic
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- Hematological Malignancies
- Solid Tumors
- Autoimmune Diseases
- Genetic Disorders
- Neurological Disorders
- Others
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Hospitals and Cancer Centers
- Pharmaceutical and Biotechnology Companies
- Contract Development and Manufacturing Organizations (CDMOs)
- Academic and Research Institutes
- Specialized Cell Therapy Centers
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Novartis AG
- Bristol-Myers Squibb Company
- Gilead Sciences, Inc.
- Johnson & Johnson
- Legend Biotech Corporation
- Autolus Therapeutics plc
- Iovance Biotherapeutics, Inc.
- Adaptimmune Therapeutics plc
- Allogene Therapeutics, Inc.
- CRISPR Therapeutics AG
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Next Generation Cell Therapy Market, By Cell Type
- Global Next Generation Cell Therapy Market, By Therapy Type
- Global Next Generation Cell Therapy Market, By Source
- Global Next Generation Cell Therapy Market, By Application
- Global Next Generation Cell Therapy Market, By End User
- Global Next Generation Cell Therapy Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Cell Type Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Industry Trends
4. Global Next Generation Cell Therapy Market, By Cell Type, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- T Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Natural Killer (NK) Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Stem Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Dendritic Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Macrophages
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Next Generation Cell Therapy Market, By Therapy Type, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- CAR-T Cell Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- T-Cell Receptor (TCR) Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Tumor-Infiltrating Lymphocyte (TIL) Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- CAR-NK Cell Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Stem Cell Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Next Generation Cell Therapy Market, By Source, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Autologous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Allogeneic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Next Generation Cell Therapy Market, By Application, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hematological Malignancies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Solid Tumors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Autoimmune Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Genetic Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
8. Global Next Generation Cell Therapy Market, By End User, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals and Cancer Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Contract Development and Manufacturing Organizations (CDMOs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Specialized Cell Therapy Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
9. Global Next Generation Cell Therapy Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Cell Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Cell Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Cell Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Cell Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Cell Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Cell Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Novartis AG
- Company Highlights
- Cell Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bristol-Myers Squibb Company
- Company Highlights
- Cell Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- Gilead Sciences, Inc.
- Company Highlights
- Cell Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson
- Company Highlights
- Cell Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- Legend Biotech Corporation
- Company Highlights
- Cell Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- Autolus Therapeutics plc
- Company Highlights
- Cell Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- Iovance Biotherapeutics, Inc.
- Company Highlights
- Cell Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- Adaptimmune Therapeutics plc
- Company Highlights
- Cell Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- Allogene Therapeutics, Inc.
- Company Highlights
- Cell Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- CRISPR Therapeutics AG
- Company Highlights
- Cell Type Portfolio
- Key Developments
- Financial Performance
- Strategies
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
